Drug Shortage Report for TRISENOX

Last updated on 2020-05-14 History
Report ID 115216
Drug Identification Number 02407833
Brand name TRISENOX
Common or Proper name TRISENOX 10MG/10ML 10X10ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ARSENIC TRIOXIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-05-13
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-05-14
Company comments Item is to be discontinued - TRISENOX 12MG/6ML 10X6ML INJ SOL is now available.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-05-14 French Compare
v1 2020-05-14 English Compare